GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BTG PLC (OTCPK:BTGGF) » Definitions » EPS (Diluted)

BTG (BTGGF) EPS (Diluted) : $0.29 (TTM As of Mar. 2019)


View and export this data going back to . Start your Free Trial

What is BTG EPS (Diluted)?

BTG's Earnings per Share (Diluted) for the six months ended in Mar. 2019 was $0.09. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2019 was $0.29.

BTG's EPS (Basic) for the six months ended in Mar. 2019 was $0.09. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2019 was $0.29.

BTG's EPS without NRI for the six months ended in Mar. 2019 was $0.09. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2019 was $0.29.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


BTG EPS (Diluted) Historical Data

The historical data trend for BTG's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BTG EPS (Diluted) Chart

BTG Annual Data
Trend Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.22 0.11 0.04 0.29

BTG Semi-Annual Data
Sep09 Mar10 Sep10 Mar11 Sep11 Mar12 Sep12 Mar13 Sep13 Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.18 -0.14 0.20 0.09

Competitive Comparison of BTG's EPS (Diluted)

For the Biotechnology subindustry, BTG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BTG's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BTG's PE Ratio distribution charts can be found below:

* The bar in red indicates where BTG's PE Ratio falls into.



BTG EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

BTG's Diluted EPS for the fiscal year that ended in Mar. 2019 is calculated as

Diluted EPS (A: Mar. 2019 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(110.4-0)/391.000
=0.28

BTG's Diluted EPS for the quarter that ended in Mar. 2019 is calculated as

Diluted EPS (Q: Mar. 2019 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(33-0)/392.400
=0.08

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2019 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BTG  (OTCPK:BTGGF) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


BTG EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of BTG's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


BTG (BTGGF) Business Description

Traded in Other Exchanges
N/A
Address
5 Fleet Place, London, GBR, EC4M 7RD
BTG is a biotechnology company that develops products in specialty areas of medicine. The company's three operating segments are interventional medicine, specialty pharmaceuticals, and licensing. Its interventional medicine focuses on oncology, vascular treatments, and pulmonology. BTG's revenue is roughly split between these three segments, while its oncology operations lead the interventional segment. The company has been known to utilize acquisitions for investing in leading therapies and capabilities.